1. Home
  2. CTSO vs VTSI Comparison

CTSO vs VTSI Comparison

Compare CTSO & VTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.73

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$4.98

Market Cap

61.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
VTSI
Founded
1997
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
49.7M
61.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
VTSI
Price
$0.73
$4.98
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$5.38
$7.00
AVG Volume (30 Days)
123.7K
57.5K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$36,979,520.00
$24,934,267.00
Revenue This Year
$11.93
N/A
Revenue Next Year
$21.22
$13.39
P/E Ratio
N/A
$353.35
Revenue Growth
23.89
N/A
52 Week Low
$0.60
$3.57
52 Week High
$1.61
$7.51

Technical Indicators

Market Signals
Indicator
CTSO
VTSI
Relative Strength Index (RSI) 45.33 42.84
Support Level $0.70 $4.79
Resistance Level $0.85 $5.13
Average True Range (ATR) 0.07 0.22
MACD 0.01 0.04
Stochastic Oscillator 47.16 38.03

Price Performance

Historical Comparison
CTSO
VTSI

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

Share on Social Networks: